NeuroSense Therapeutics L...

NASDAQ: NRSN · Real-Time Price · USD
1.21
-0.01 (-0.82%)
At close: May 15, 2025, 10:42 AM

NeuroSense Therapeutics Statistics

Share Statistics

NeuroSense Therapeutics has 23.99M shares outstanding. The number of shares has increased by 28.78% in one year.

Shares Outstanding 23.99M
Shares Change (YoY) 28.78%
Shares Change (QoQ) 0.45%
Owned by Institutions (%) 3.58%
Shares Floating n/a
Failed to Deliver (FTD) Shares 5,275
FTD / Avg. Volume 3.52%

Short Selling Information

The latest short interest is 163.71K, so 0.68% of the outstanding shares have been sold short.

Short Interest 163.71K
Short % of Shares Out 0.68%
Short % of Float 0.83%
Short Ratio (days to cover) 1.87

Valuation Ratios

The PE ratio is -2.19 and the forward PE ratio is -2.29. NeuroSense Therapeutics's PEG ratio is 0.06.

PE Ratio -2.19
Forward PE -2.29
PS Ratio 0
Forward PS 0.8
PB Ratio 8.64
P/FCF Ratio -2.2
PEG Ratio 0.06
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for NeuroSense Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.03.

Current Ratio 2.21
Quick Ratio 2.21
Debt / Equity 0.03
Debt / EBITDA -0.01
Debt / FCF -0.01
Interest Coverage -31.84

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee $-600,588.24
Employee Count 17
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 1.34, so NeuroSense Therapeutics's price volatility has been higher than the market average.

Beta 1.34
52-Week Price Change n/a
50-Day Moving Average 1.05
200-Day Moving Average 1.07
Relative Strength Index (RSI) 67.29
Average Volume (20 Days) 149,826

Income Statement

Revenue n/a
Gross Profit -22K
Operating Income -9.9M
Net Income -10.21M
EBITDA -9.88M
EBIT -9.9M
Earnings Per Share (EPS) -0.55
Full Income Statement

Balance Sheet

The company has 3.38M in cash and 73K in debt, giving a net cash position of 3.31M.

Cash & Cash Equivalents 3.38M
Total Debt 73K
Net Cash 3.31M
Retained Earnings -36.66M
Total Assets 4.58M
Working Capital 2.41M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.13M and capital expenditures -3K, giving a free cash flow of -10.14M.

Operating Cash Flow -10.13M
Capital Expenditures -3K
Free Cash Flow -10.14M
FCF Per Share -0.54
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NRSN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for NRSN is $14, which is 1066.7% higher than the current price. The consensus rating is "Hold".

Price Target $14
Price Target Difference 1066.7%
Analyst Consensus Hold
Analyst Count 2
Stock Forecasts

Scores

Altman Z-Score -9.93
Piotroski F-Score 2